FRANK WANG is listed as an executive officer and director on 4 SEC Form D filings by 1 issuer between Jan 2014 and Jul 2017: BioMedomics, Inc. (Research Triangle Park, NC — biotechnology — 2014–2017; $690K reported sold to 13 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside J. ROBERT TYLER, III (2 shared filings), CAM PATTERSON (1 shared filing), LIN WU (1 shared filing), PHILLIP S. WISE (1 shared filing) and TOM ROBERG (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around FRANK. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 4 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for FRANK WANG and found 7 differences, 1 worth asking the sponsor about: Form D filed 70 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.